37 results
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
, contributions, and market data Short-Term Incentive Corporate Performance Goals – 100% Product (5%) Program (30%) Pipeline (20%) Financial (15%) Functional … a 4-year period Rationale Goals intended to motivate and reward the achievement of Vir’s most critical drivers of near-term success and, where
8-K
VIR
Vir Biotechnology Inc
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
and patient impact. The Company is making purpose-led changes to align with its goals and ensure the Company is well-positioned for the future. These changes
8-K
EX-99.2
wyge s8qv
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
8-K
EX-99.1
t82qojb6
28 Jun 21
Other Events
6:07am
8-K
EX-99.2
9u4d29io3h1efs
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
nf2b2r36znmyjs
13 Apr 21
Other Events
4:06pm